Aberrant expression of five miRNAs in papillary thyroid carcinomas

Area of Science:

• Molecular Biology
• Oncology
• Genetics

Background:

• MicroRNAs (miRNAs) are crucial regulators in tumor progression.
• Their aberrant expression is implicated in various cancers, including thyroid malignancies.
• Identifying specific miRNAs in papillary thyroid carcinoma (PTC) is essential for understanding disease mechanisms.

Purpose of the Study:

• To screen and identify specific miRNAs involved in PTC.
• To evaluate the diagnostic and prognostic potential of these identified miRNAs in PTC.

Main Methods:

• Quantitative real-time PCR was used to measure miRNA expression levels.
• Expression analysis was performed on PTC tissues, adjacent PTC (A-PTC) tissues, benign nodules, and adjacent benign nodules.
• Receiver Operating Characteristic (ROC) curve analysis was employed to assess diagnostic accuracy.

Main Results:

• Significant downregulation of miR-1296-5p, miR-1301-3p, and miR-532-5p observed in PTC.
• Significant upregulation of miR-551b-3p and miR-455-3p noted in PTC.
• Expression levels of these miRNAs correlated with clinicopathological features such as tumor size, TNM stage, and lymph node metastasis.

Conclusions:

• Aberrant expression of five specific miRNAs (miR-1296-5p, miR-1301-3p, miR-532-5p, miR-551b-3p, and miR-455-3p) is evident in PTC.
• These miRNAs show potential as diagnostic biomarkers, supported by ROC analysis.
• The identified miRNAs may serve as valuable prognostic biomarkers for PTC.